| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 10.69 | 0.15 (+1.42%) | 6.93 - 12.30 | 276.2 thousand (Below Avg) |
Market data as of 4:00PM 05/24/13. Quotes are delayed by at least 15 min.
| Open | 10.50 |
|---|---|
| Previous Close | 10.54 |
| Day's Range | 10.48 - 10.75 |
| Market Cap | 685.2M |
| Avg Volume (10 Day) | 844.4K |
| Price/Earnings (Trailing 12 Mo.) | -- |
| Earnings Per Share (Trailing 12 Mo.) | -0.86 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Pass |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Fail |
| Increased shareholder value? | Fail |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Neutral |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Pass |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Pass |
| Has sufficient liquidity? | Pass |
Exact Sciences to Participate in May Investor Conferences
Business Wire - Friday 05/03/2013 10:30 AM ET
Exact Sciences Reports First-Quarter 2013 Financial Results, Announces Addition to Board of Directors
Business Wire - Wednesday 05/01/2013 7:30 AM ET
Exact Sciences to Host First-Quarter 2013 Results Webcast and Call
Business Wire - Friday 04/26/2013 1:15 PM ET
| EXAS | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | -0.36% | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | 0.02 | |
| LT Debt/Equity | 0.02 | |
| Earnings Yield | -- | |
| Price/Sales | 165.34 |
| Company | Last | Change |
|---|---|---|
| Array Biopharma Inc | 5.85 | +3.36% |
| Optimer Pharmaceuticals Inc | 14.48 | -1.30% |
| China Biologic Products Inc | 26.52 | +0.08% |
| Achillion Pharmaceuticals Inc | 7.58 | -0.79% |
| Dendreon Corp | 3.89 | -0.51% |
Data is delayed by at least 15 min.